Geriatric depression is a common psychiatric illness affecting as many
as one-third of the older population. With the growing number of elde
rly in many countries of the world, the morbidity and mortality associ
ated with untreated and partially treated depression is of great conce
rn from both a medical and economic perspective. Depression in the eld
erly often presents with more somatic or anxious features and less of
the subjective sadness expressed by younger groups. In addition, in th
e elderly, depressive-spectrum disorders (which include minor depressi
on, dysthymia, mixed anxiety/depression, bereavement-related depressio
n and even suicidal ideation) are generally under-recognised and under
treated by health professionals. The clinical mismatch between high pr
evalence but undertreatment stems from patient and physician attitudes
toward depression as a 'normal' response to aging and loss, diagnosti
cally confusing medical illness-related symptomatology, and noncomplia
nce with prescribed treatment. Furthermore, late-onset depression may
hold special prognostic value in the elderly, with the relationship be
tween late-onset depression and cerebrovascular events and progressive
dementing illness being particularly strong. Therapeutically, then ha
s been a recent expansion in the pharmacological tools that can be use
d to treat depression. A variety of new agents are now available that
have adverse effect, pharmacodynamic and target-receptor profiles that
differ from the older agents. For example, newer drugs that block the
serotonin (5-hydroxytryptamine; 5-HT) transporter have supplanted old
er agents that cause more frequent and toxic adverse effects. These ne
wer agents have also focused attention on the impact of polypharmacy o
n the hepatic cytochrome P450 system, which is responsible for drug me
tabolism and elimination. Electroconvulsive therapy and psychotherapy
remain effective nonpharmacological treatments for geriatric depressio
n. Generally, the opportunities for therapeutic intervention in geriat
ric depression suggest that greater diagnostic attention and more wide
spread application of treatments for this increasingly prevalent disor
der continue to be needed.